Caricamento...
Drugging PI3K in cancer: refining targets and therapeutic strategies
The phosphatidylinositol-3 kinase (PI3K) pathway is one of the most frequently activated pathogenic signalling routes in human cancers, making it a rational and important target for innovative anticancer drug development and precision medicine. The three main classes of PI3K inhibitors currently in...
Salvato in:
| Pubblicato in: | Curr Opin Pharmacol |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier Science Ltd
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4728196/ https://ncbi.nlm.nih.gov/pubmed/26117819 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.coph.2015.05.016 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|